Published in Brain Pathol on May 01, 2010
The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow. Brain (2012) 1.01
Age-related white matter changes. J Aging Res (2011) 0.93
Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol (2013) 0.92
Network structure of brain atrophy in de novo Parkinson's disease. Elife (2015) 0.85
Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease. J Neural Transm (Vienna) (2011) 0.83
Contributions of academic laboratories to the discovery and development of chemical biology tools. J Med Chem (2013) 0.81
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study. Lancet Neurol (2016) 0.79
Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. J Neural Transm (Vienna) (2012) 0.79
Subclinical visuospatial impairment in Parkinson's disease: the role of Basal Ganglia and limbic system. Front Neurol (2014) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord (2008) 5.72
Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology (2005) 3.29
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology (2009) 3.04
Changes in network activity with the progression of Parkinson's disease. Brain (2007) 2.46
The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology (1997) 2.36
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology (2009) 2.23
Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology (1996) 2.23
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry (2008) 2.12
Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol (1983) 2.06
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain (2004) 2.06
Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol (2003) 1.94
Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage (2006) 1.92
Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol (1983) 1.91
Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia. J Neurol (2005) 1.65
Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry (2003) 1.56
Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Ann Neurol (1989) 1.54
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology (2005) 1.54
Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology (2005) 1.47
Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology (2008) 1.45
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.39
Parkinson's disease is associated with hippocampal atrophy. Mov Disord (2003) 1.37
Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol (2000) 1.36
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol (2004) 1.33
Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology (2005) 1.28
Cognitive dysfunction and dementia in Parkinson's disease. J Neural Transm (Vienna) (2004) 1.28
Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain (2002) 1.27
Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp (2004) 1.26
Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol (2008) 1.24
Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J Neurol Neurosurg Psychiatry (2004) 1.24
[11C]PIB binding in Parkinson's disease dementia. Neuroimage (2007) 1.24
Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol (2005) 1.18
Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain (2000) 1.17
Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett (1999) 1.16
Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord (2008) 1.15
Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol (2005) 1.07
Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry (2002) 1.06
Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia. J Neurol (2008) 1.05
Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage (2003) 1.05
Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm (Vienna) (2001) 1.03
Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett (2001) 1.03
Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain (2005) 1.02
Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol Aging (2005) 1.02
Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov Disord (2005) 1.01
Hippocampal atrophy is related to impaired memory, but not frontal functions in non-demented Parkinson's disease patients. Neuroreport (1998) 1.01
Dementia in Parkinson's disease. Curr Opin Neurol (2008) 1.00
Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method. Ann Neurol (1984) 1.00
Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch Neurol (1992) 1.00
Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease. Psychiatry Res (2007) 0.98
Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord (2005) 0.97
Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. Brain (2002) 0.96
A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur J Neurol (2007) 0.96
Dementia in Parkinson's disease: diffusion tensor imaging. Acta Neurol Scand (2007) 0.95
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med (1997) 0.94
Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease. Neurobiol Aging (2007) 0.94
The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J Neurol Sci (1999) 0.94
Alzheimer disease and the dementia of Parkinson disease: comparative investigations. Alzheimer Dis Assoc Disord (1990) 0.90
Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J Neural Transm (Vienna) (2000) 0.90
Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study. Parkinsonism Relat Disord (2008) 0.89
MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias. J Neurol Sci (2007) 0.89
SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry (1992) 0.89
Functional effects of striatal dysfunction in Parkinson disease. Arch Neurol (1997) 0.88
Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging. Dement Geriatr Cogn Disord (2005) 0.88
Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT. Eur J Nucl Med Mol Imaging (2005) 0.85
Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain (1992) 0.84
In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia. Neuroimage (2006) 0.81
Twelve-month follow-up study of regional cerebral blood flow in Parkinson's disease. Dementia (1995) 0.79
Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci (2001) 0.78
Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease--a rCBF scintigraphy study. Acta Neurol Scand (2007) 0.78
Grey matter atrophy in early versus late dementia in Parkinson's disease. Parkinsonism Relat Disord (2008) 0.77
Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease. J Neurol Neurosurg Psychiatry (1993) 0.76
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med (2005) 12.04
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol (2003) 3.75
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55
The trajectory of gait speed preceding mild cognitive impairment. Arch Neurol (2010) 2.66
Status of computerized cognitive testing in aging: a systematic review. Alzheimers Dement (2008) 2.52
Unobtrusive and ubiquitous in-home monitoring: a methodology for continuous assessment of gait velocity in elders. IEEE Trans Biomed Eng (2009) 2.30
Dementia assessment in primary care: results from a study in three managed care systems. J Gerontol A Biol Sci Med Sci (2004) 1.86
Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord (2005) 1.82
Ecology of the aging human brain. Arch Neurol (2011) 1.78
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep (2003) 1.58
Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet (2002) 1.56
Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J Alzheimers Dis (2005) 1.55
Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol (2008) 1.52
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement (2009) 1.49
Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2. Alzheimers Dement (2011) 1.29
Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology (2013) 1.29
Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci (2003) 1.22
Behavioral change in persons with dementia: relationships with mental and physical health of caregivers. J Gerontol B Psychol Sci Soc Sci (2002) 1.19
Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol (2014) 1.18
Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging. PLoS One (2011) 1.12
apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice. Neurobiol Aging (2005) 1.03
Assessment of cognition in mild cognitive impairment: a comparative study. Alzheimers Dement (2011) 1.00
Unobtrusive assessment of walking speed in the home using inexpensive PIR sensors. Conf Proc IEEE Eng Med Biol Soc (2009) 0.99
Supervised and Unsupervised Feature Selection for Inferring Social Nature of Telephone Conversations from Their Content. Proc IEEE Workshop Autom Speech Recognit Underst (2003) 0.98
F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease. J Mol Neurosci (2007) 0.97
Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients. Alzheimer Dis Assoc Disord (2007) 0.96
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
Measuring motor speed through typing: a surrogate for the finger tapping test. Behav Res Methods (2011) 0.95
Assessment of cognition in early dementia. Alzheimers Dement (2011) 0.94
Role of biomarkers in studies of presymptomatic Alzheimer's disease. Alzheimers Dement (2005) 0.94
Spoken Language Derived Measures for Detecting Mild Cognitive Impairment. IEEE Trans Audio Speech Lang Process (2011) 0.93
Predictors of normal and successful aging among urban-dwelling elderly Brazilians. J Gerontol B Psychol Sci Soc Sci (2009) 0.92
Pilot study to show the feasibility of a multicenter trial of home-based assessment of people over 75 years old. Alzheimer Dis Assoc Disord (2010) 0.92
A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers Dis (2014) 0.91
Efficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions. Neuropsychol Rev (2013) 0.91
The role of technology and engineering models in transforming healthcare. IEEE Rev Biomed Eng (2013) 0.88
Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain. J Alzheimers Dis (2003) 0.88
The FAS gene, brain volume, and disease progression in Alzheimer's disease. Alzheimers Dement (2009) 0.88
Incidence of mild cognitive impairment and Alzheimer disease in Southern Brazil. J Geriatr Psychiatry Neurol (2009) 0.87
Continuous activity monitoring and intelligent contextual prompting to improve medication adherence. Conf Proc IEEE Eng Med Biol Soc (2007) 0.87
On the Disambiguation of Passively Measured In-home Gait Velocities from Multi-person Smart Homes. J Ambient Intell Smart Environ (2011) 0.87
Measuring changes in activity patterns during a norovirus epidemic at a retirement community. Conf Proc IEEE Eng Med Biol Soc (2011) 0.86
Dementia-free survival among centenarians: an evidence-based review. J Gerontol A Biol Sci Med Sci (2006) 0.86
Willingness of older adults to share data and privacy concerns after exposure to unobtrusive in-home monitoring. Gerontechnology (2013) 0.85
MobileRF: A Robust Device-Free Tracking System Based On a Hybrid Neural Network HMM Classifier. Proc ACM Int Conf Ubiquitous Comput (2014) 0.83
A systematic review of clinician and staff views on the acceptability of incorporating remote monitoring technology into primary care. Telemed J E Health (2014) 0.82
MRS in relation to hippocampal volume in the oldest old. Neurology (2003) 0.81
Hello, Who is Calling?: Can Words Reveal the Social Nature of Conversations? Proc Conf (2012) 0.80
Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease. Arch Neurol (2002) 0.80
The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage (2011) 0.79
Predictors of the progression of dementia severity in brazilian patients with Alzheimer's disease and vascular dementia. Int J Alzheimers Dis (2010) 0.78
[Application of the Brazilian version of the CDR scale in samples of dementia patients]. Arq Neuropsiquiatr (2006) 0.78
Technology use by rural and urban oldest old. Technol Health Care (2009) 0.78
Developing dementia prevention trials: baseline report of the Home-Based Assessment study. Alzheimer Dis Assoc Disord (2013) 0.78
Dementia specialists and early adoption of amyloid imaging. J Alzheimers Dis (2013) 0.78
Random local temporal structure of category fluency responses. J Comput Neurosci (2011) 0.77
Unobtrusive monitoring of the longitudinal evolution of in-home gait velocity data with applications to elder care. Conf Proc IEEE Eng Med Biol Soc (2011) 0.77
The impact of sleep on neuropsychological performance in cognitively intact older adults using a novel in-home sensor-based sleep assessment approach. Clin Neuropsychol (2015) 0.76
Inferring Social Nature of Conversations from Words: Experiments on a Corpus of Everyday Telephone Conversations. Comput Speech Lang (2014) 0.76
Microcephaly genes and risk of late-onset Alzheimer disease. Alzheimer Dis Assoc Disord (2011) 0.75
Kernels for longitudinal data with variable sequence length and sampling intervals. Neural Comput (2011) 0.75
Unobtrusive assessment of mobility. Conf Proc IEEE Eng Med Biol Soc (2006) 0.75